How nm23-H1 Affects Cisplatin Resistance in Oesophageal Cancer Cells
Author Information
Author(s): lizuka N, Miyamoto K, Tangoku A, Hayashi H, Hazama S, Yoshino S, Yoshimura K, Hirose K, Yoshida H, Oka M
Primary Institution: Department of Bioregulatory Function, Department of Surgery II, Yamaguchi University School of Medicine
Hypothesis
The study investigates the association of nm23-H1 expression with cisplatin-induced DNA damage in oesophageal squamous cell carcinoma (OSCC).
Conclusion
Reduced expression of nm23-H1 in OSCC cells is linked to resistance against cisplatin by preventing DNA damage.
Supporting Evidence
- YES-2/AS-12 cells showed significantly reduced expression of nm23-H1 protein compared to parental YES-2 cells.
- YES-2/AS-12 cells were more resistant to DNA damage from cisplatin than YES-2/Neo cells.
- Mitochondrial membrane potentials and DNA fragmentation assays confirmed that YES-2/AS-12 was more resistant to cisplatin-induced apoptosis.
Takeaway
This study found that when a certain protein (nm23-H1) is less present in cancer cells, those cells can better resist damage from a cancer drug called cisplatin.
Methodology
The study used antisense nm23-H1 transfectants to analyze DNA damage and drug resistance in OSCC cell lines.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website